BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 6875481 0 FOR 6875481 FOR Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 8563 0 AGAINST 8563 AGAINST Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 8563 0 ONE YEAR 8563 FOR Personalis, Inc. 71535D106 US71535D1063 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 24802 0 FOR 24802 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES 9507 0 FOR 9507 FOR Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES 11427 0 FOR 11427 FOR Illumina, Inc. 452327109 US4523271090 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 5709 0 FOR 5709 FOR Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 4961 0 ONE YEAR 4961 AGAINST Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2302393 0 AGAINST 2302393 AGAINST Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2302393 0 ONE YEAR 2302393 FOR Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 7721 0 FOR 7721 FOR Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 76162 0 FOR 76162 FOR Neurogene Inc. 64135M105 US64135M1053 06/03/2026 To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 265138 0 FOR 265138 FOR Neurogene Inc. 64135M105 US64135M1053 06/03/2026 To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years. SECTION 14A SAY-ON-PAY VOTES 265138 0 ONE YEAR 265138 FOR Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 723767 0 AGAINST 723767 AGAINST 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES 42660 0 FOR 42660 FOR Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 14971 0 AGAINST 14971 AGAINST Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 20655 0 AGAINST 20655 AGAINST Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 9807883 0 FOR 9807883 FOR Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES 276308 0 FOR 276308 FOR Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES 36493 0 AGAINST 36493 AGAINST Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 206973 0 FOR 206973 FOR Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 18810 0 FOR 18810 FOR Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 18810 0 ONE YEAR 18810 FOR Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 165323 0 AGAINST 165323 AGAINST Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 87932732 0 FOR 87932732 FOR Structure Therapeutics Inc. 86366E106 US86366E1064 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 906363 0 FOR 906363 FOR Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2750 0 FOR 2750 FOR GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3007164 0 FOR 3007164 FOR GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES 3007164 0 ONE YEAR 3007164 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission (""Say-on-Pay""). SECTION 14A SAY-ON-PAY VOTES 2577333 0 FOR 2577333 FOR